- Email: [email protected]
DECONSTRUCTING DELIRIUM: RETHINKING THE ROLE OF BIOMARKERS AND DIAGNOSTIC ANOMALIES
AAGP Annual Meeting 2019 Assurex - Scientific/Medical Advisory Board Member Avid - Other Financial or Material Support UpToDate - Other Financial or Material Support Ruth Morin Nothing to disclose
2018 HIGHLIGHTED PAPERS FOR THE GERIATRIC MENTAL HEALTH CLINICAL PROVIDER Session 400 1 2 3 4 Juan Young ; Laurel Bessey ; Melanie Scharrer ; Silpa Balachandran 1
Case Western Reserve University MetroHealth Psychiatry University of Wisconsin School of Medicine and Public Health, Madison, WI 3 University of Wisconsin School of Medicine and Public Health, Madison, WI 4 Metrohealth Medical Center 2
Abstract: Geriatric psychiatrists and other geriatric mental health providers face several competing demands for their attention and time. Numerous scientific advances in this growing field are published each year. Providers are expected to engage in lifelong learning and to practice evidence-based medicine. This session will provide busy geriatric psychiatrists and mental health providers a highlighted overview of several of the most relevant updates pertaining to the clinical practice of geriatric psychiatry that have been published from the year 2018. We hope that after attending this session, the audience will find the information presented useful for their clinical practice and can disseminate these updates to their colleagues. This will promote efficient learning, application of acquired knowledge to clinical practice, and help busy providers who also serve as experts in geriatric psychiatry to disseminate knowledge about up-to-date advances to their colleagues back home. Faculty Disclosures Juan Young Nothing to disclose Laurel Bessey Nothing to disclose Melanie Scharrer Nothing to disclose Silpa Balachandran Nothing to disclose
DECONSTRUCTING DELIRIUM: RETHINKING THE ROLE OF BIOMARKERS AND DIAGNOSTIC ANOMALIES Session 401 1 2 3 4 5 6 Babar A. Khan ; Carol Chan ; Heidi Lindroth ; Jeffrey Browndyke ; Jo Ellen Wilson ; Sophia Wang 1
Indiana University School of Medicine Johns Hopkins Hospital, Baltimore, MD 3 Indiana University School of Medicine 4 Duke University Medical Center 5 Vanderbilt University Medical Center, Nolensville, TN 6 Indiana University School of Medicine 2
Abstract: The DSM-5 definition for delirium relies solely on clinical criteria. Recent developments in the National Institute on Aging-Alzheimer’s Association (NIA-AA) research framework have challenged clinicians to reflect on their approach for major and mild neurocognitive disorders, particularly with regards to biomarkers and preclinical Alzheimer’s disease. The implications of the NIA-AA research framework for delirium have not been fully explored. Given the overlap between delirium and dementia
S38
Am J Geriatr Psychiatry 27:3S, March 2019
AAGP Annual Meeting 2019 (major neurocognitive disorder), this is a crucial area of future study. Furthermore, there has been growing recognition of the clinical significance of a number of diagnostic entities that do not neatly fit within the DSM-5 criteria. These include patients who are at high risk for developing delirium, comorbid delirium and catatonia, and long-term cognitive impairment from delirium. This presentation will cover the role of biomarkers in delirium and perioperative cognitive disorders and these diagnostic anomalies. Finally, there will be audience-driven discussion on how future research can incorporate our current knowledge of delirium biomarkers into the current NIA-AA research framework, whether the discussed diagnostic anomalies should challenge clinicians to rethink the DSM-5 criteria for delirium, and how our current knowledge about biomarkers and diagnostic anomalies may change clinical practice. Faculty Disclosures Babar Khan Nothing to disclose Carol Chan Nothing to disclose Heidi Lindroth Nothing to disclose Jeffrey Browndyke Claret Medical − Consultant Jo Ellen Wilson Nothing to disclose Sophia Wang APPI - Book royalties
PSYCHOPHARMACOLOGY: FACT OR FICTION, PART 2 Session 4021 2 Amy Hebbard ; Jessica L Broadway 1
Medical University of South Carolina Medical University of South Carolina
2
Abstract: Psychopharmacology is complex with many theories explaining mechanisms of action, but relatively few conclusive studies. This lack of high quality evidence often leads to misconceptions and possibly false beliefs, as well as perpetuation of anecdotal experiences with medications. This presentation aims to examine several commonly used medications in geriatric psychiatry and compare the existing evidence to theoretical effects and side-effects. We will also compare and contrast available evidence to support or refute theories and anecdotal experiences. Faculty Disclosures Amy Hebbard Nothing to disclose Jessica Broadway Nothing to disclose
ADVOCATING FOR OLDER ADULTS: WHEN GUARDIANSHIP IS NOT THE ANSWER Session 403 1 2 3 4 Alessandra Scalmati ; Dennis M Popeo ; Elizabeth J Santos ; Erica Cristina Garcia-Pittman 1
Albert Einstein College of Medicine NYU School of Medicine 3 University of Rochester School of Medicine & Dentistry, Rochester, NY 4 Dell Medical School j The University of Texas at Austin 2
Am J Geriatr Psychiatry 27:3S, March 2019
S39
2018 HIGHLIGHTED PAPERS FOR THE GERIATRIC MENTAL HEALTH CLINICAL PROVIDER Session 400 1 2 3 4 Juan Young ; Laurel Bessey ; Melanie Scharrer ; Silpa Balachandran 1
Case Western Reserve University MetroHealth Psychiatry University of Wisconsin School of Medicine and Public Health, Madison, WI 3 University of Wisconsin School of Medicine and Public Health, Madison, WI 4 Metrohealth Medical Center 2
Abstract: Geriatric psychiatrists and other geriatric mental health providers face several competing demands for their attention and time. Numerous scientific advances in this growing field are published each year. Providers are expected to engage in lifelong learning and to practice evidence-based medicine. This session will provide busy geriatric psychiatrists and mental health providers a highlighted overview of several of the most relevant updates pertaining to the clinical practice of geriatric psychiatry that have been published from the year 2018. We hope that after attending this session, the audience will find the information presented useful for their clinical practice and can disseminate these updates to their colleagues. This will promote efficient learning, application of acquired knowledge to clinical practice, and help busy providers who also serve as experts in geriatric psychiatry to disseminate knowledge about up-to-date advances to their colleagues back home. Faculty Disclosures Juan Young Nothing to disclose Laurel Bessey Nothing to disclose Melanie Scharrer Nothing to disclose Silpa Balachandran Nothing to disclose
DECONSTRUCTING DELIRIUM: RETHINKING THE ROLE OF BIOMARKERS AND DIAGNOSTIC ANOMALIES Session 401 1 2 3 4 5 6 Babar A. Khan ; Carol Chan ; Heidi Lindroth ; Jeffrey Browndyke ; Jo Ellen Wilson ; Sophia Wang 1
Indiana University School of Medicine Johns Hopkins Hospital, Baltimore, MD 3 Indiana University School of Medicine 4 Duke University Medical Center 5 Vanderbilt University Medical Center, Nolensville, TN 6 Indiana University School of Medicine 2
Abstract: The DSM-5 definition for delirium relies solely on clinical criteria. Recent developments in the National Institute on Aging-Alzheimer’s Association (NIA-AA) research framework have challenged clinicians to reflect on their approach for major and mild neurocognitive disorders, particularly with regards to biomarkers and preclinical Alzheimer’s disease. The implications of the NIA-AA research framework for delirium have not been fully explored. Given the overlap between delirium and dementia
S38
Am J Geriatr Psychiatry 27:3S, March 2019
AAGP Annual Meeting 2019 (major neurocognitive disorder), this is a crucial area of future study. Furthermore, there has been growing recognition of the clinical significance of a number of diagnostic entities that do not neatly fit within the DSM-5 criteria. These include patients who are at high risk for developing delirium, comorbid delirium and catatonia, and long-term cognitive impairment from delirium. This presentation will cover the role of biomarkers in delirium and perioperative cognitive disorders and these diagnostic anomalies. Finally, there will be audience-driven discussion on how future research can incorporate our current knowledge of delirium biomarkers into the current NIA-AA research framework, whether the discussed diagnostic anomalies should challenge clinicians to rethink the DSM-5 criteria for delirium, and how our current knowledge about biomarkers and diagnostic anomalies may change clinical practice. Faculty Disclosures Babar Khan Nothing to disclose Carol Chan Nothing to disclose Heidi Lindroth Nothing to disclose Jeffrey Browndyke Claret Medical − Consultant Jo Ellen Wilson Nothing to disclose Sophia Wang APPI - Book royalties
PSYCHOPHARMACOLOGY: FACT OR FICTION, PART 2 Session 4021 2 Amy Hebbard ; Jessica L Broadway 1
Medical University of South Carolina Medical University of South Carolina
2
Abstract: Psychopharmacology is complex with many theories explaining mechanisms of action, but relatively few conclusive studies. This lack of high quality evidence often leads to misconceptions and possibly false beliefs, as well as perpetuation of anecdotal experiences with medications. This presentation aims to examine several commonly used medications in geriatric psychiatry and compare the existing evidence to theoretical effects and side-effects. We will also compare and contrast available evidence to support or refute theories and anecdotal experiences. Faculty Disclosures Amy Hebbard Nothing to disclose Jessica Broadway Nothing to disclose
ADVOCATING FOR OLDER ADULTS: WHEN GUARDIANSHIP IS NOT THE ANSWER Session 403 1 2 3 4 Alessandra Scalmati ; Dennis M Popeo ; Elizabeth J Santos ; Erica Cristina Garcia-Pittman 1
Albert Einstein College of Medicine NYU School of Medicine 3 University of Rochester School of Medicine & Dentistry, Rochester, NY 4 Dell Medical School j The University of Texas at Austin 2
Am J Geriatr Psychiatry 27:3S, March 2019
S39